Ardent Health, Inc. (ARDT)
| Market Cap | 2.03B +71.2% |
| Revenue (ttm) | 6.45B +2.0% |
| Net Income | 146.22M -28.7% |
| EPS | 1.03 -28.7% |
| Shares Out | 140.94M |
| PE Ratio | 13.99 |
| Forward PE | 11.05 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 7,270,112 |
| Open | 13.75 |
| Previous Close | 17.75 |
| Day's Range | 13.46 - 14.53 |
| 52-Week Range | 7.71 - 18.57 |
| Beta | 0.58 |
| Analysts | Buy |
| Price Target | 17.38 (+20.69%) |
| Earnings Date | Nov 4, 2026 |
About ARDT
Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free... [Read more]
Financial Performance
In 2025, Ardent Health's revenue was $6.32 billion, an increase of 6.01% compared to the previous year's $5.97 billion. Earnings were $135.81 million, a decrease of -35.43%.
Financial StatementsAnalyst Summary
According to 13 analysts, the average rating for ARDT stock is "Buy." The 12-month stock price target is $17.38, which is an increase of 20.69% from the latest price.
News
Eight Ardent Health Facilities Earn ‘A' Hospital Safety Grades from The Leapfrog Group for Fall 2026 Grading Period
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that eight of its facilities ear...
Ardent Health falls -19.8%
Ardent Health (ARDT) is down -19.8%, or -$3.51 to $14.24.
Ardent Health falls -19.4%
Ardent Health (ARDT) is down -19.4%, or -$3.45 to $14.30.
Ardent Health 8M share Spot Secondary priced at $14.50
JPMorgan and Barclays are acting as joint book running managers for the offering. The deal size was increased to 8.0M shares from 7.0M and priced below last closing price of…
Ardent Health Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health, Inc. (NYSE: ARDT) (“Ardent Health” or the “Company”) today announced the pricing of the previously announced secondary public offering (the “Offering”...
CORRECTING and REPLACING Ardent Health Announces Proposed Secondary Offering of Common Stock and Concurrent Share Repurchase
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Please replace the release with the following corrected version due to multiple revisions. The updated release reads: ARDENT HEALTH ANNOUNCES PROPOSED SECONDARY OFFE...
Ardent Health announces offering of 7M shares of common stock for holders
Ardent Health (ARDT) announced the commencement of a proposed secondary public offering of 6.24M shares of its common stock by an affiliate of Equity Group Investments and 755K shares of…
Ardent Health Announces Proposed Secondary Offering of Common Stock and Concurrent Share Repurchase
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health, Inc. (NYSE: ARDT) (“Ardent Health” or the “Company”) today announced the commencement of a proposed secondary public offering (the “Offering”) of 6,24...
Ardent Health price target raised to $22 from $13 at Truist
Truist raised the firm’s price target on Ardent Health (ARDT) to $22 from $13 and keeps a Buy rating on the shares. The firm is adjusting its estimates to reflect…
Ardent Health price target raised to $14 from $12 at BofA
BofA raised the firm’s price target on Ardent Health (ARDT) to $14 from $12 and keeps an Underperform rating on the shares after the company agreed to buy Boone Health,…
Ardent Health Transcript: M&A announcement
Boone Health will be acquired for ~$47 million, with closing expected in Q1 2027. The plan targets at least $30 million in annual synergies by year three and commits $200 million of CapEx over 10 years.
Ardent Health Slides: M&A announcement
Ardent Health has posted slides in relation to its latest quarterly earnings report, which was published on November 12, 2026.
Ardent Health Press release: M&A announcement
Ardent Health issued a press release on November 12, 2026, disclosing material business information to investors.
Ardent Health to acquire Boone Health for $47M in cash
Ardent Health (ARDT) “announced a definitive agreement to acquire Boone Health, a not-for-profit health system based in Columbia, Missouri, for a purchase price of $47 million in cash. The acquisition...
Ardent Health Announces Definitive Agreement to Acquire Boone Health
BRENTWOOD, Tenn. & COLUMBIA, Mo.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced a definitive agr...
Ardent Health price target raised to $21 from $13 at Mizuho
Mizuho raised the firm’s price target on Ardent Health (ARDT) to $21 from $13 and keeps an Outperform rating on the shares. The firm upped targets in the acute care…
Ardent Health Transcript: UBS Global Healthcare Conference
IMPACT savings and operating improvements remain central as surgical demand lags strong top-of-funnel activity. For 2027, priorities include converting referrals, investing in OR capacity and pursuing disciplined acquisitions in growing markets.
Ardent Health Slides: UBS Global Healthcare Conference
Ardent Health has posted slides in relation to its latest quarterly earnings report, which was published on November 10, 2026.
Ardent Health to Participate in the UBS Global Healthcare Conference
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that the Company will participat...
Ardent Health price target raised to $13.50 from $12 at Morgan Stanley
Morgan Stanley analyst Craig Hettenbach raised the firm’s price target on Ardent Health (ARDT) to $13.50 from $12 and keeps an Equal Weight rating on the shares. Published first on…
Ardent Health price target raised to $21 from $13 at Stephens
Stephens raised the firm’s price target on Ardent Health (ARDT) to $21 from $13 and keeps an Overweight rating on the shares.
Ardent Health Earnings Call Transcript: Q3 2026
Q3 revenue was $1.62B and adjusted EBITDA was $138M, supported by improved admissions and lower labor costs. FY26 adjusted EBITDA guidance midpoint rose 1.5%, while Kansas hospital divestiture and continued IMPACT savings shape the growth and margin plan.
Ardent Health Earnings release: Q3 2026
Ardent Health released its Q3 2026 earnings on November 5, 2026, summarizing the period's financial results.
Ardent Health Slides: Q3 2026
Ardent Health has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on November 5, 2026.
Ardent Health Quarterly report: Q3 2026
Ardent Health has published its Q3 2026 quarterly earnings report on November 5, 2026.